Please ensure Javascript is enabled for purposes of website accessibility

PSS World Medical Meets on the Top Line, Misses Where it Counts

By Seth Jayson - Updated Apr 7, 2017 at 11:50AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Just the facts, Fool.

PSS World Medical (Nasdaq: PSSI) reported earnings on Nov. 7. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Sep. 28 (Q2), PSS World Medical met expectations on revenues and missed estimates on earnings per share.

Compared to the prior-year quarter, revenue contracted significantly and GAAP earnings per share dropped significantly.

Gross margins expanded, operating margins shrank, net margins dropped.

Revenue details
PSS World Medical booked revenue of $420.8 million. The eight analysts polled by S&P Capital IQ anticipated net sales of $426.2 million on the same basis. GAAP reported sales were 19% lower than the prior-year quarter's $521.8 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.25. The six earnings estimates compiled by S&P Capital IQ predicted $0.29 per share. GAAP EPS of $0.31 for Q2 were 16% lower than the prior-year quarter's $0.37 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 33.8%, 180 basis points better than the prior-year quarter. Operating margin was 6.4%, 60 basis points worse than the prior-year quarter. Net margin was 3.6%, 20 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $432.0 million. On the bottom line, the average EPS estimate is $0.30.

Next year's average estimate for revenue is $1.71 billion. The average EPS estimate is $1.11.

Investor sentiment
The stock has a one-star rating (out of five) at Motley Fool CAPS, with 61 members out of 75 rating the stock outperform, and 14 members rating it underperform. Among 30 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 25 give PSS World Medical a green thumbs-up, and five give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on PSS World Medical is hold, with an average price target of $21.69.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
327%
 
S&P 500 Returns
116%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/20/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.